Clinical Trials for Aadi Bioscience

Explore 6 clinical trials worldwide

Showing 1-6 of 6 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: Aadi Bioscience

Clinical Trials (6)

NCT06494150
Nab-Sirolimus and Endocrine Therapy in Recurrent Low Grade Serous Ovarian Cancer (NARETO)
PHASE2Recruiting
37 participants
Started: Dec 26, 2024 · Completed: Sep 30, 2029
1 condition2 sponsors1 location
NCT06308419
A Phase I Trial of Combination Gemcitabine and Nab-Sirolimus in Advanced Leiomyosarcomas or Advanced Soft-Tissue Sarcomas With TSC2 or TSC1 Loss-of-function Mutations or Deletions
PHASE1Recruiting
12 participants
Started: Aug 14, 2024 · Completed: Feb 1, 2031
2 conditions2 sponsors1 location
NCT05997017
Trial of Nab-Sirolimus in Combination With Letrozole in Patients With Advanced or Recurrent Endometrioid Endometrial Cancer
PHASE2Recruiting
29 participants
Started: Dec 28, 2023 · Completed: Oct 31, 2026
6 conditions1 sponsor9 locations
NCT05997056
Trial of Nab-sirolimus in Patients With Well-differentiated Neuroendocrine Tumors (NETs) of the Gastrointestinal Tract, Lung, or Pancreas Who Have Not Received Prior Treatment With mTOR Inhibitors
PHASE2Recruiting
21 participants
Started: Nov 7, 2023 · Completed: Dec 8, 2025
5 conditions1 sponsor4 locations
NCT05661461
Dose-escalation Study to Assess Safety and Pharmacokinetics of Nab-Sirolimus in Patients With Locally Advanced or Metastatic Solid Tumors and Moderate Liver Impairment
PHASE1Recruiting
28 participants
Started: Nov 23, 2022 · Completed: Apr 1, 2025
3 conditions1 sponsor2 locations
NCT05103358
Phase 2 Basket Trial of Nab-sirolimus in Patients With Malignant Solid Tumors With Pathogenic Alterations in TSC1/TSC2 Genes (PRECISION 1)
PHASE2Active, not recruiting
120 participants
Started: Feb 15, 2022 · Completed: Dec 31, 2025
21 conditions1 sponsor166 locations